7 active trials 4 recruiting 15 disease areas 4 changes in 30 days
| Early Phase 1 | 2 | |
| Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06777433 | Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases | Brain Metastases From Solid Tumors | Active, Not Recruiting | 2026-08-12 |
| Phase 1/2 | ||||
| NCT07189871 | 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or… | Castration-Resistant Prostate Cancer (CRPC) | Recruiting | 2026-10-01 |
| NCT07259213 | A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC | Castration-resistant Prostate Cancer | Recruiting | 2026-04-01 |
| Phase 1 | ||||
| NCT05799274 | Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other… | Healthy Volunteers | Active, Not Recruiting | 2026-09-14 |
| NCT07272642 | A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced… | Imaging | Not Yet Recruiting | 2026-08-12 |
| Early Phase 1 | ||||
| NCT06824155 | HEAT Trial (HER2 Antibody Therapy With Lutetium-177) | HER2 Gene Mutation | Recruiting | 2026-09-24 |
| NCT06305962 | 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors | PDL1 Gene Mutation | Recruiting | 2026-02-19 |
Lung Cancer (4) · Non-Small Cell Lung Cancer (NSCLC) (4) · Breast Cancer (3) · Endometrial Cancer (3) · Head & Neck Cancer (3) · Triple-Negative Breast Cancer (3) · Cervical Cancer (2) · Colorectal Cancer (2) · Esophageal Cancer (2) · Ovarian Cancer (2)